Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade.

Umelo IA, De Wever O, Kronenberger P, Van Deun J, Noor A, Singh K, Teugels E, Chen G, Bracke M, De Greve J
Oncotarget. 2015 Aug 21;6(24):20132-44. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.